Skip to main content
Erschienen in: Intensive Care Medicine 11/2003

01.11.2003 | Brief Report

Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia

verfasst von: G. Christopher Wood, Scott D. Hanes, Bradley A. Boucher, Martin A. Croce, Timothy C. Fabian

Erschienen in: Intensive Care Medicine | Ausgabe 11/2003

Einloggen, um Zugang zu erhalten

Abstract

Objective

To report the use of tetracyclines for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP).

Design

Observational case series.

Setting

The Presley Regional Trauma Center located within the Regional Medical Center, Memphis, Tennessee, USA.

Patients and participants

Seven critically ill trauma patients with VAP caused by A. baumannii isolates that were resistant to all antibiotics tested except for doxycycline or minocycline.

Interventions

Patients were treated with IV doxycycline or minocycline for an average of 13.5 (range 9–20) days.

Measurements and results

Doxycycline or minocycline was successful in six of seven patients.

Conclusions

Doxycycline or minocycline may be effective for treating multidrug-resistant A. baumannii VAP.
Literatur
1.
Zurück zum Zitat American Thoracic Society (1995) Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. A consensus statement. Am J Respir Crit Care Med 153:1711–1725 American Thoracic Society (1995) Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. A consensus statement. Am J Respir Crit Care Med 153:1711–1725
2.
Zurück zum Zitat Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J (2001) Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: Geographic patterns, epidemiological features, and trends in the SENTRY antimicrobial surveillance program (1997–1999). Clin Infect Dis 32(Suppl ii):104–113CrossRef Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J (2001) Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: Geographic patterns, epidemiological features, and trends in the SENTRY antimicrobial surveillance program (1997–1999). Clin Infect Dis 32(Suppl ii):104–113CrossRef
3.
Zurück zum Zitat Wood GC, Hanes SD, Croce MA, Fabian TC, Boucher BA (2002) Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of Acinetobacter ventilator-associated pneumonia. Clin Infect Dis 34:1425–1430CrossRefPubMed Wood GC, Hanes SD, Croce MA, Fabian TC, Boucher BA (2002) Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of Acinetobacter ventilator-associated pneumonia. Clin Infect Dis 34:1425–1430CrossRefPubMed
4.
Zurück zum Zitat Rodríguez-Hernández MJ, Pachón J, Pichardo C, Cuberos L, Ibánez-Martínez J, García-Curiel A, Caballero FJ, Moreno I, Jiménez-Mejías ME (2000) Imipenem, doxycycline and amikacin in monotherapy in combination in Acinetobacter baumannii experimental pneumonia. J Antimicrob Chemother 45:493–501CrossRefPubMed Rodríguez-Hernández MJ, Pachón J, Pichardo C, Cuberos L, Ibánez-Martínez J, García-Curiel A, Caballero FJ, Moreno I, Jiménez-Mejías ME (2000) Imipenem, doxycycline and amikacin in monotherapy in combination in Acinetobacter baumannii experimental pneumonia. J Antimicrob Chemother 45:493–501CrossRefPubMed
5.
Zurück zum Zitat Croce MA, Fabian TC, Waddle-Smith L, Melton SM, Minard G, Kudsk KA, Pritchard FE (1998) Utility of Gram’s stain and efficacy of quantitative cultures for posttraumatic pneumonia: A prospective study. Ann Surg 227:743–755PubMed Croce MA, Fabian TC, Waddle-Smith L, Melton SM, Minard G, Kudsk KA, Pritchard FE (1998) Utility of Gram’s stain and efficacy of quantitative cultures for posttraumatic pneumonia: A prospective study. Ann Surg 227:743–755PubMed
6.
Zurück zum Zitat Leibovici L, Paul M, Poznanski O, Drucker M, Samra Z, Konigsburger H, Pitlik SD (1997) Monotherapy versus lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother 41:1127–1133PubMed Leibovici L, Paul M, Poznanski O, Drucker M, Samra Z, Konigsburger H, Pitlik SD (1997) Monotherapy versus lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother 41:1127–1133PubMed
7.
Zurück zum Zitat DuPont H, Carbon C, Carlet J (2000) Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. Antimicrob Agents Chemother 44:2028–2033CrossRefPubMed DuPont H, Carbon C, Carlet J (2000) Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. Antimicrob Agents Chemother 44:2028–2033CrossRefPubMed
8.
Zurück zum Zitat Cometta A, Baumgartner JD, Lew D, Zimmerli W, Pittet D, Chopart P, Schaad U, Herter C, Eggimann P, Huber O, Ricou B, Suter P, Auckenthaler R, Chiolero R, bille J, Scheidegger C, Frei R, Glauser MP (1994) Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients. Antimicrob Agents Chemother 38:1309–1313PubMed Cometta A, Baumgartner JD, Lew D, Zimmerli W, Pittet D, Chopart P, Schaad U, Herter C, Eggimann P, Huber O, Ricou B, Suter P, Auckenthaler R, Chiolero R, bille J, Scheidegger C, Frei R, Glauser MP (1994) Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients. Antimicrob Agents Chemother 38:1309–1313PubMed
9.
Zurück zum Zitat Croce MA, Fabian TC, Stewart RM, Pritchard FE, Minard G, Trenthem L, Kudsk KA (1993) Empiric monotherapy versus combination therapy of nosocomial pneumonia in trauma patients. J Trauma 35:303–311PubMed Croce MA, Fabian TC, Stewart RM, Pritchard FE, Minard G, Trenthem L, Kudsk KA (1993) Empiric monotherapy versus combination therapy of nosocomial pneumonia in trauma patients. J Trauma 35:303–311PubMed
10.
Zurück zum Zitat Urban C, Go E, Mariano N, Berger BJ, Avraham I, Rubin D, Rahal JJ (1993) Effect of sulbactam on infection caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J Infect Dis 167:448–451PubMed Urban C, Go E, Mariano N, Berger BJ, Avraham I, Rubin D, Rahal JJ (1993) Effect of sulbactam on infection caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J Infect Dis 167:448–451PubMed
11.
Zurück zum Zitat Jiménez-Mejías ME, Pachón J, Becerril B, Palomino-Nicas J, Rodriguez-Cobacho A, Revuelta M (1997) Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam. Clin Infect Dis 24:932–935PubMed Jiménez-Mejías ME, Pachón J, Becerril B, Palomino-Nicas J, Rodriguez-Cobacho A, Revuelta M (1997) Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam. Clin Infect Dis 24:932–935PubMed
12.
Zurück zum Zitat Cisneros JM, Reyes MJ, Pachón J, Becerril B, Caballero FJ, Garcia-Garmendia JL, Ortiz C, Cobacho AR (1996) Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis 22:1026–1032PubMed Cisneros JM, Reyes MJ, Pachón J, Becerril B, Caballero FJ, Garcia-Garmendia JL, Ortiz C, Cobacho AR (1996) Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis 22:1026–1032PubMed
13.
Zurück zum Zitat Jellison TK, McKinnon PS, Rybak MJ (2001) Epidemiology, resistance, and outcomes of Acinetobacter baumannii bactermia treated with imipenem-cilastatin or ampicillin-sulbactam. Pharmacotherapy 21:142–148PubMed Jellison TK, McKinnon PS, Rybak MJ (2001) Epidemiology, resistance, and outcomes of Acinetobacter baumannii bactermia treated with imipenem-cilastatin or ampicillin-sulbactam. Pharmacotherapy 21:142–148PubMed
14.
Zurück zum Zitat Corbella X, Ariza J, Ardanuy C, Vuelta M, Tabau F, Sora M, Pujol M, Gudiol F (1998) Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. J Antimicrob Chemother 42:793–802 Corbella X, Ariza J, Ardanuy C, Vuelta M, Tabau F, Sora M, Pujol M, Gudiol F (1998) Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. J Antimicrob Chemother 42:793–802
15.
Zurück zum Zitat Jiménez-Mejías ME, Becerril B, Márquez-Rivas FJ, Pichardo C, Cuberos L, Pachon J (2000) Successful treatment of multidrug-resistant Acinetobacter baumannii meningitis with intravenous colistin sulfomethate sodium. Eur J Clin Microbiol Inf Dis 19:970–971CrossRef Jiménez-Mejías ME, Becerril B, Márquez-Rivas FJ, Pichardo C, Cuberos L, Pachon J (2000) Successful treatment of multidrug-resistant Acinetobacter baumannii meningitis with intravenous colistin sulfomethate sodium. Eur J Clin Microbiol Inf Dis 19:970–971CrossRef
16.
Zurück zum Zitat Wood CA, Reboli AC (1993) Infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J Infect Dis 168:1602–1603PubMed Wood CA, Reboli AC (1993) Infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J Infect Dis 168:1602–1603PubMed
17.
Zurück zum Zitat Levin AS, Barone AA, Penço J, Santos MV, Marinho IS, Arruda EA, Manrique EI, Costa SF (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 28:1008–1011PubMed Levin AS, Barone AA, Penço J, Santos MV, Marinho IS, Arruda EA, Manrique EI, Costa SF (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 28:1008–1011PubMed
18.
Zurück zum Zitat Fernandez-Viladrich P, Corbella X, Corral F, Tubau F, Mateu A (1999) Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium. Clin Infect Dis 28:916–917PubMed Fernandez-Viladrich P, Corbella X, Corral F, Tubau F, Mateu A (1999) Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium. Clin Infect Dis 28:916–917PubMed
19.
Zurück zum Zitat Wood GC, Boucher BA (2000) Aerosolized antimicrobial therapy in acutely ill patients. Pharmacotherapy 20:166–181PubMed Wood GC, Boucher BA (2000) Aerosolized antimicrobial therapy in acutely ill patients. Pharmacotherapy 20:166–181PubMed
20.
Zurück zum Zitat Wolff M, Joly-Guillou ML, Farinotti R, Carbon C (1999) In vivo efficacies of combinations of -lactams, -lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model. Antimicrob Agents Chemother 43:1406–1411PubMed Wolff M, Joly-Guillou ML, Farinotti R, Carbon C (1999) In vivo efficacies of combinations of -lactams, -lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model. Antimicrob Agents Chemother 43:1406–1411PubMed
Metadaten
Titel
Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia
verfasst von
G. Christopher Wood
Scott D. Hanes
Bradley A. Boucher
Martin A. Croce
Timothy C. Fabian
Publikationsdatum
01.11.2003
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 11/2003
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-003-1811-2

Weitere Artikel der Ausgabe 11/2003

Intensive Care Medicine 11/2003 Zur Ausgabe

Tipps für den Umgang mit Behandlungsfehlern

01.05.2024 DGIM 2024 Kongressbericht

Es ist nur eine Frage der Zeit, bis es zu einem Zwischenfall kommt und ein Behandlungsfehler passiert. Doch wenn Ärztinnen und Ärzte gut vorbereitet sind, schaffen es alle Beteiligten den Umständen entsprechend gut durch diese Krise. 

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.